Clinical trials in Guinea
48 studies list at least one site in Guinea. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-16.
Get an email when these change. Save the studies in Guinea recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
ANRS, Emerging Infectious Diseases (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Drugs for Neglected Diseases (4) · Institut de Recherche pour le Developpement (3) · Institute for Research and Development of Medicinal and Food Plants of Guinea (2) · Institut National de la Santé Et de la Recherche Médicale, France (2) · McGill University (2) · Centre National de Formation et de Recherche en Sante Rurale (2)
What changed recently
From the registry's own updates since Oct 11, 2026.
First site in Guinea1
Studies
Recruiting first, then most recently updated. Showing 48 of 48 — search for more.
- An International Observational Study of Adults With Acute InfectionRecruitingNCT07069400
- Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis TreatmentRecruitingNCT07477119Phase 4
- Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : GuineaNot yet recruitingNCT07534267
- Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOPRecruitingNCT04794296
- EBOla Post-Exposure ProphylaxisNot yet recruitingNCT06841614Phase 3
- Febrile Illness in GuineaRecruitingNCT06122259
- Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed NewbornsCompletedNCT05017558
- Investigation of Immune Amnesia Following Measles Infection in Select African RegionsCompletedNCT06153979
- Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric PatientsCompletedNCT05433350Phase 2/3
- Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune SuppressionCompletedNCT04738812Phase 3
- International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)CompletedNCT05096091
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.CompletedNCT03923725Phase 3
- Efficacy of Favipiravir Against Ebola (JIKI)CompletedNCT02329054Phase 2
- Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. GambienseCompletedNCT03087955Phase 2/3
- A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in InfantsCompletedNCT03929757Phase 2
- Safety and Tolerability Study of Acoziborole in g-HAT Seropositive SubjectsCompletedNCT05256017Phase 2/3
- Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the SemenTerminatedNCT02739477Phase 2
- Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StageCompletedNCT03025789Phase 3
- Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, GuineaCompletedNCT04969913
- Partnership for Research on Ebola VACcinationsCompletedNCT02876328Phase 2
- Prospective Evaluation of the Specificity of Serological Tests for Human African TrypanosomiasisCompletedNCT05466630Not applicable
- Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in GuineaActive, not recruitingNCT05409300Phase 2
- Malaria Prevalence Around Maferinyah, GuineaCompletedNCT04105855
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary TuberculosisCompletedNCT02581527Phase 3
- Dolutegravir and Darunavir Evaluation in Adults Failing TherapyStatus unknownNCT03017872Phase 4
- DIAgnostics for Multidrug Resistant Tuberculosis in AfricaCompletedNCT03303963
- Immune Response to a Delayed Second Dose of Oral Cholera VaccineStatus unknownNCT05453253Phase 4
- Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 InfectionStatus unknownNCT04920838Phase 2/3
- GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in SemenCompletedNCT02818582Phase 2
- Prophylaxis Vaccine Antibodies EbolaStatus unknownNCT04822376Phase 2
- Africa COVID-19 Vaccine HesitancyCompletedNCT04912284
- COVID-19 STAndard of Care in Sub-Saharan AfricaCompletedNCT04885543
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case DetectionCompletedNCT03356665Not applicable
- International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-CombiCompletedNCT03072030Phase 4
- Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 PatientsStatus unknownNCT04501965Phase 2
- Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 PatientsStatus unknownNCT04502342Phase 2
- HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV ExposureCompletedNCT03642704Phase 4
- Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in GuineaCompletedNCT02342171Phase 2/3
- Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola InfectionCompletedNCT02363322Phase 1/2
- A Survey of Hospitalizations in Cardiology Units in Sub-Saharan AfricaStatus unknownNCT03231449
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)CompletedNCT00170209Phase 3
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectivenessCompletedNCT00931736Phase 3
- Recurrence and Pregnancy Post-repair of Obstetric Fistula in GuineaCompletedNCT02686957
- Improving Access to HbA1c in Sub Saharan AfricaCompletedNCT01460095Not applicable
- Non-inferiority of Short-term Catheterization Following Fistula Repair SurgeryCompletedNCT01428830Not applicable
- Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216333Phase 4
- Study of the Management of Vaginal Discharge in West African Using Single Dose TreatmentsCompletedNCT00313131Phase 3
- A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216385Phase 3